Highlight Therapeutics SL Employee Directory

Biotechnology ResearchSpain11-50 Employees

Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.  Its lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target approach to turn ‘cold’ tumors ‘hot’ and therefore visible to the immune system.  It has the potential to rescue patients who are resistant to current checkpoint inhibitor therapy.  BO-112 is currently being investigated in a range of clinical trials as a monotherapy and in combination with checkpoint inhibitors. In addition to in-house research, Highlight Therapeutics has a number of external collaborators, including Merck & Co and UCLA.

Find Highlight Therapeutics SL employees' phone numbers or email addresses

Highlight Therapeutics SL Global Highlights

Location
Employees

Europe
14

Minus sign iconPlus sign icon
  • Spain
    13
  • Switzerland
    1

Highlight Therapeutics SL's Leadership

  • Stylized image of a person
    M. D.
    Ceo And Member Of The Board
    Phone icon
  • Stylized image of a person
    A. R.
    Chief Business Officer
    Phone icon
  • Stylized image of a person
    D. T.
    Board Member & Co-Founder
    Phone icon
  • Stylized image of a person
    E. M.
    Global Cmc Lead
    Phone icon
  • Stylized image of a person
    K. G.
    Legal Consultant
    Phone icon
  • Stylized image of a person
    E. C.
    Laboratory Manager (cmc)
    Phone icon

Highlight Therapeutics SL Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Entrepreneurship
  • Human Resources
  • Legal
  • Other

Contact profiles from Highlight Therapeutics SL

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    M. D.
    Ceo And Member Of The Board
    Phone icon
    SpainCatalonia
    Dec 18, 2025
  • Stylized image of a person
    D. T.
    Board Member & Co-Founder
    Phone icon
    Jan 28, 2026
  • Stylized image of a person
    A. R.
    Chief Business Officer
    Phone icon
    Switzerland
    Nov 19, 2025
  • Stylized image of a person
    E. M.
    Global Cmc Lead
    Phone icon
    SpainCommunity of Madrid
    Jan 28, 2026
  • Stylized image of a person
    K. G.
    Legal Consultant
    Phone icon
    SpainMadrid
    Oct 23, 2025
  • Stylized image of a person
    E. C.
    Laboratory Manager (cmc)
    Phone icon
    SpainValencian Community
    Jan 28, 2026

Frequently Asked Questions

What is Highlight Therapeutics SL known for?

Minus sign iconPlus sign icon
Highlight Therapeutics SL operates in the Biotechnology Research industry. The company's main headquarters is located in Spain; you can contact the main corporate office by phone at . Explore Highlight Therapeutics SL's company overview page for more information.

What is Highlight Therapeutics SL's most common email format?

Minus sign iconPlus sign icon
Highlight Therapeutics SL employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Highlight Therapeutics SL email formats with LeadIQ.

How many employees does Highlight Therapeutics SL have currently?

Minus sign iconPlus sign icon
Highlight Therapeutics SL has approximately 18 employees as of February 2026. These team members are located across 1 continents, including Europe.

Who are Highlight Therapeutics SL's key employees and leadership?

Minus sign iconPlus sign icon

As of February 2026, Highlight Therapeutics SL's key employees include:

  • Ceo And Member Of The Board: M. D.
  • Chief Business Officer: A. R.
  • Board Member & Co-Founder: D. T.
  • Global Cmc Lead: E. M.
  • Legal Consultant: K. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.